Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.
about
Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapyThe novel immunotherapeutic oligodeoxynucleotide IMT504 protects neutropenic animals from fatal Pseudomonas aeruginosa bacteremia and sepsisProposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
P2860
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.
@ast
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.
@en
type
label
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.
@ast
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.
@en
prefLabel
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.
@ast
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.
@en
P2093
P2860
P356
P1476
Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide.
@en
P2093
Alejandro D Montaner
Andrés Hernando-Insúa
Carlos Nagle
David L Horn
Fernanda Elías
Jorge Zorzopulos
Juan M Rodriguez
Néstor Lago
Raúl Franco
P2860
P304
P356
10.1089/NAT.2013.0479
P577
2014-04-10T00:00:00Z